{ "api_version": "1", "request": { "url": "https://clinicaltrialsfind.com/api/v1/search.json?intervention=A6&page=3", "query": { "intervention": "A6", "page": 3 }, "page_size": 10 }, "pagination": { "page": 3, "page_size": 10, "total_count": 1136, "total_pages": 114, "next_page_url": "https://clinicaltrialsfind.com/api/v1/search.json?intervention=A6&page=4&page_size=10", "previous_page_url": "https://clinicaltrialsfind.com/api/v1/search.json?intervention=A6&page=2&page_size=10" }, "source": "remote", "last_synced_at": "2026-10-09T21:47:40.179Z", "attribution": "Data derived from public ClinicalTrials.gov records. The official record at https://clinicaltrials.gov/ remains the source of truth for current availability, contacts, and full study details.", "notes": [ "This endpoint exposes only public summary fields — no participant contact emails, phone numbers, or scraped investigator contact details.", "For contact information and full protocol detail, follow each trial's `official_url` to the ClinicalTrials.gov record.", "This API is a navigational aid. It does not provide medical advice, eligibility determinations, or compensation guarantees." ], "trials": [ { "nct_id": "NCT01499082", "title": "Comparison of a New Formulation of Insulin Glargine With Lantus in Patients With Type 2 Diabetes Mellitus on Basal Plus Mealtime Insulin", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Type 2 Diabetes Mellitus" ], "interventions": [ { "name": "HOE901-U300 (new formulation of insulin glargine)", "type": "DRUG" }, { "name": "Lantus (insulin glargine)", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Sanofi", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 807, "start_date": "2011-12", "completion_date": "2013-09", "has_results": true, "last_update_posted_date": "2022-03-25", "last_synced_at": "2026-10-09T21:47:40.179Z", "location_count": 95, "location_summary": "Chandler, Arizona • Glendale, Arizona • Phoenix, Arizona + 78 more", "locations": [ { "city": "Chandler", "state": "Arizona" }, { "city": "Glendale", "state": "Arizona" }, { "city": "Phoenix", "state": "Arizona" }, { "city": "Sun City", "state": "Arizona" }, { "city": "Tempe", "state": "Arizona" } ], "official_url": "https://clinicaltrials.gov/study/NCT01499082" }, { "nct_id": "NCT04063813", "title": "Parameters of Exercise to Prevent Osteoporosis", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "NA" ], "conditions": [ "Osteoporosis, Postmenopausal" ], "interventions": [ { "name": "Experimental: 40 minute up trial", "type": "BEHAVIORAL" }, { "name": "Experimental: 40 minute down trial", "type": "BEHAVIORAL" }, { "name": "Experimental: Two 20 minute up trials", "type": "BEHAVIORAL" }, { "name": "Experimental: Two 20 min down trials", "type": "BEHAVIORAL" }, { "name": "Active Comparator: Sedentary trial", "type": "BEHAVIORAL" } ], "intervention_types": [ "BEHAVIORAL" ], "sponsor": "University of Michigan", "sponsor_class": "OTHER", "healthy_volunteers": true, "eligibility": { "minimum_age": "50 Years", "maximum_age": "65 Years", "sex": "FEMALE", "summary": "50 Years to 65 Years · Female only" }, "enrollment_count": 40, "start_date": "2007-05-15", "completion_date": "2010-08-19", "has_results": false, "last_update_posted_date": "2019-08-21", "last_synced_at": "2026-10-09T21:47:40.179Z", "location_count": 1, "location_summary": "Ann Arbor, Michigan", "locations": [ { "city": "Ann Arbor", "state": "Michigan" } ], "official_url": "https://clinicaltrials.gov/study/NCT04063813" }, { "nct_id": "NCT00556218", "title": "Meditation and Cognitive Function in Women With Breast Cancer", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "NA" ], "conditions": [ "Breast Cancer" ], "interventions": [ { "name": "Tibetan Meditation Program", "type": "BEHAVIORAL" }, { "name": "No Meditation", "type": "BEHAVIORAL" } ], "intervention_types": [ "BEHAVIORAL" ], "sponsor": "M.D. Anderson Cancer Center", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "FEMALE", "summary": "18 Years and older · Female only" }, "enrollment_count": 47, "start_date": "2007-10-24", "completion_date": "2022-08-10", "has_results": false, "last_update_posted_date": "2022-08-30", "last_synced_at": "2026-10-09T21:47:40.179Z", "location_count": 1, "location_summary": "Houston, Texas", "locations": [ { "city": "Houston", "state": "Texas" } ], "official_url": "https://clinicaltrials.gov/study/NCT00556218" }, { "nct_id": "NCT01910727", "title": "Together on Diabetes Study: Evaluation of a Pilot Diabetes Prevention and Management Program for American Indian Youth", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "NA" ], "conditions": [ "Diabetes" ], "interventions": [ { "name": "Together on Diabetes-Hopkins", "type": "BEHAVIORAL" } ], "intervention_types": [ "BEHAVIORAL" ], "sponsor": "Johns Hopkins Bloomberg School of Public Health", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "10 Years", "maximum_age": "19 Years", "sex": "ALL", "summary": "10 Years to 19 Years" }, "enrollment_count": 506, "start_date": "2011-12", "completion_date": "2015-07", "has_results": false, "last_update_posted_date": "2017-03-20", "last_synced_at": "2026-10-09T21:47:40.179Z", "location_count": 1, "location_summary": "Baltimore, Maryland", "locations": [ { "city": "Baltimore", "state": "Maryland" } ], "official_url": "https://clinicaltrials.gov/study/NCT01910727" }, { "nct_id": "NCT05220254", "title": "Stanford Tobacco Treatment Services - Virtual Reality Treatment for Smoking Cessation", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "NA" ], "conditions": [ "Smoking Cessation", "MindCotine Virtual Reality Mindful Exposure Therapy" ], "interventions": [ { "name": "MindCotine's VR app", "type": "BEHAVIORAL" } ], "intervention_types": [ "BEHAVIORAL" ], "sponsor": "Stanford University", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 20, "start_date": "2021-10-18", "completion_date": "2022-10-27", "has_results": true, "last_update_posted_date": "2023-12-18", "last_synced_at": "2026-10-09T21:47:40.179Z", "location_count": 1, "location_summary": "Palo Alto, California", "locations": [ { "city": "Palo Alto", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT05220254" }, { "nct_id": "NCT01021397", "title": "Safety of and Immune Response to Recombinant Live Attenuated Parainfluenza Type 3 Virus Vaccine in Healthy Infants and Children", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE1" ], "conditions": [ "Paramyxoviridae Infections", "Virus Diseases" ], "interventions": [ { "name": "rHPIV3cp45", "type": "DRUG" }, { "name": "rHPIV3cp45 placebo", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "National Institute of Allergy and Infectious Diseases (NIAID)", "sponsor_class": "NIH", "healthy_volunteers": true, "eligibility": { "minimum_age": "6 Months", "maximum_age": "36 Months", "sex": "ALL", "summary": "6 Months to 36 Months" }, "enrollment_count": 12, "start_date": "2009-11", "completion_date": "2011-12", "has_results": false, "last_update_posted_date": "2013-01-03", "last_synced_at": "2026-10-09T21:47:40.179Z", "location_count": 2, "location_summary": "Baltimore, Maryland • Seattle, Washington", "locations": [ { "city": "Baltimore", "state": "Maryland" }, { "city": "Seattle", "state": "Washington" } ], "official_url": "https://clinicaltrials.gov/study/NCT01021397" }, { "nct_id": "NCT03300024", "title": "Bovine Carotid Artery Biologic Graft and Expanded Polytetrafluoroethylene for Permanent Hemodialysis Access", "overall_status": "TERMINATED", "study_type": "INTERVENTIONAL", "phases": [ "NA" ], "conditions": [ "End Stage Renal Disease", "Hemolysis", "Arteriovenous Graft" ], "interventions": [ { "name": "Expanded polytetrafluoroethylene Graft", "type": "DEVICE" }, { "name": "Bovine Carotid Artery Graft", "type": "DEVICE" } ], "intervention_types": [ "DEVICE" ], "sponsor": "Johns Hopkins University", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "90 Years", "sex": "ALL", "summary": "18 Years to 90 Years" }, "enrollment_count": 10, "start_date": "2015-02-01", "completion_date": "2018-02-12", "has_results": true, "last_update_posted_date": "2019-05-21", "last_synced_at": "2026-10-09T21:47:40.179Z", "location_count": 1, "location_summary": "Baltimore, Maryland", "locations": [ { "city": "Baltimore", "state": "Maryland" } ], "official_url": "https://clinicaltrials.gov/study/NCT03300024" }, { "nct_id": "NCT02600741", "title": "Family Intervention in Recent Onset Schizophrenia Treatment (FIRST)", "overall_status": "COMPLETED", "study_type": "OBSERVATIONAL", "phases": [], "conditions": [ "Schizophrenia" ], "interventions": [ { "name": "Caregiver psycho-education and skills training", "type": "OTHER" }, { "name": "Caregiver support available at the study site", "type": "OTHER" }, { "name": "Paliperidone palmitate", "type": "DRUG" }, { "name": "Chlorpromazine", "type": "DRUG" }, { "name": "Droperidol", "type": "DRUG" }, { "name": "Fluphenazine", "type": "DRUG" }, { "name": "Haloperidol", "type": "DRUG" }, { "name": "Loxapine", "type": "DRUG" }, { "name": "Perphenazine", "type": "DRUG" }, { "name": "Pimozide", "type": "DRUG" }, { "name": "Prochlorperazine", "type": "DRUG" }, { "name": "Thiothixene", "type": "DRUG" }, { "name": "Thioridazine", "type": "DRUG" }, { "name": "Trifluoperazine", "type": "DRUG" }, { "name": "Aripiprazole", "type": "DRUG" }, { "name": "Asenapine", "type": "DRUG" }, { "name": "Clozapine", "type": "DRUG" }, { "name": "Iloperidone", "type": "DRUG" }, { "name": "Olanzapine", "type": "DRUG" }, { "name": "Paliperidone", "type": "DRUG" }, { "name": "Quetiapine", "type": "DRUG" }, { "name": "Risperidone", "type": "DRUG" }, { "name": "Ziprasidone", "type": "DRUG" } ], "intervention_types": [ "OTHER", "DRUG" ], "sponsor": "Janssen Scientific Affairs, LLC", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 296, "start_date": "2015-07-24", "completion_date": "2018-07-05", "has_results": false, "last_update_posted_date": "2019-01-23", "last_synced_at": "2026-10-09T21:47:40.179Z", "location_count": 34, "location_summary": "Bullhead City, Arizona • Oceanside, California • Denver, Colorado + 31 more", "locations": [ { "city": "Bullhead City", "state": "Arizona" }, { "city": "Oceanside", "state": "California" }, { "city": "Denver", "state": "Colorado" }, { "city": "Farmington", "state": "Connecticut" }, { "city": "Lauderdale Lakes", "state": "Florida" } ], "official_url": "https://clinicaltrials.gov/study/NCT02600741" }, { "nct_id": "NCT02053103", "title": "A 6-Week Study To Determine The Safety And Effect Of An Investigational Drug On Adults With Type 2 Diabetes Mellitus Taking Metformin", "overall_status": "TERMINATED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Type 2 Diabetes Mellitus" ], "interventions": [ { "name": "PF-05175157", "type": "DRUG" }, { "name": "Placebo", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Pfizer", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "65 Years", "sex": "ALL", "summary": "18 Years to 65 Years" }, "enrollment_count": 13, "start_date": "2014-03", "completion_date": "2014-04", "has_results": false, "last_update_posted_date": "2016-05-02", "last_synced_at": "2026-10-09T21:47:40.179Z", "location_count": 1, "location_summary": "Orlando, Florida", "locations": [ { "city": "Orlando", "state": "Florida" } ], "official_url": "https://clinicaltrials.gov/study/NCT02053103" }, { "nct_id": "NCT02233088", "title": "A Pilot Study of a Lifestyle Intervention on the Metabolic Syndrome (3ELM Study)", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "NA" ], "conditions": [ "Metabolic Syndrome" ], "interventions": [ { "name": "ELM Group", "type": "BEHAVIORAL" }, { "name": "ELM Classes", "type": "OTHER" }, { "name": "ELM Individual", "type": "OTHER" } ], "intervention_types": [ "BEHAVIORAL", "OTHER" ], "sponsor": "Rush University Medical Center", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "72 Years", "sex": "ALL", "summary": "18 Years to 72 Years" }, "enrollment_count": 48, "start_date": "2013-09-20", "completion_date": "2021-12-31", "has_results": false, "last_update_posted_date": "2023-01-12", "last_synced_at": "2026-10-09T21:47:40.179Z", "location_count": 1, "location_summary": "Chicago, Illinois", "locations": [ { "city": "Chicago", "state": "Illinois" } ], "official_url": "https://clinicaltrials.gov/study/NCT02233088" } ] }